Alerts will be sent to your verified email
Verify Email
CONCORD
|
Concord Drugs
|
Tyche Inds
|
Bal Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.78 % | 12.13 % | 8.41 % |
|
5yr average Equity Multiplier
|
1.87 | 1.16 | 4.51 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 0.53 | 1.01 |
|
5yr Avg Net Profit Margin
|
1.59 % | 19.18 % | 1.86 % |
|
Price to Book
|
2.93 | 0.77 | 1.44 |
|
P/E
|
176.12 | 11.21 | 16.58 |
|
5yr Avg Cash Conversion Cycle
|
233.27 Days | 111.78 Days | 27.6 Days |
|
Inventory Days
|
152.22 Days | 69.03 Days | 99.82 Days |
|
Days Receivable
|
106.22 Days | 101.01 Days | 115.65 Days |
|
Days Payable
|
74.71 Days | 90.14 Days | 154.91 Days |
|
5yr Average Interest Coverage Ratio
|
1.69 | 2385.83 | 1.5 |
|
5yr Avg ROCE
|
8.41 % | 16.3 % | 19.2 % |
|
5yr Avg Operating Profit Margin
|
9.1 % | 21.21 % | 9.12 % |
|
5 yr average Debt to Equity
|
0.55 | 0.0 | 1.95 |
|
5yr CAGR Net Profit
|
-26.55 % | -9.09 % | 8.78 % |
|
5yr Average Return on Assets
|
1.46 % | 10.39 % | 1.88 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.39 % | 61.97 % | 50.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.39 % | 0.0 | -0.75 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Concord Drugs
|
Tyche Inds
|
Bal Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|